Lataa...
Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells
Trastuzumab has been widely used for the treatment of human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer, however, it cannot easily cross the blood-brain barrier (BBB) and is known to increase the incidence of brain metastases. In contrast, lapatinib has a low molecular wei...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5346700/ https://ncbi.nlm.nih.gov/pubmed/27738326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12597 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|